• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴氏涂片检查在宫颈癌诊断中的作用:是帮助还是阻碍?

Pap tests in the diagnosis of cervical cancer: Help or hinder?

机构信息

Department of Obstetrics and Gynecology, University of Toronto, Toronto, Ontario, Canada.

Department of Prevention and Cancer Control, Cancer Care Ontario, Toronto, Ontario, Canada.

出版信息

Gynecol Oncol. 2018 Jul;150(1):61-66. doi: 10.1016/j.ygyno.2018.05.019.

DOI:10.1016/j.ygyno.2018.05.019
PMID:29773301
Abstract

OBJECTIVE

To evaluate the impact of pap tests on the time to diagnosis of cervical cancer.

METHODS

In this population-based retrospective cohort study, Ontario women ≥21 years diagnosed with cervical cancer between 2011 and 2014 were identified and database data collected. The presence or absence of a pap test 0-2 years preceding cancer diagnosis was identified. Descriptive and modelling analyses were performed to determine the effect of pap results on cancer diagnosis.

RESULTS

2002 patients were identified, 75% received a pap test. 1250 patients had known cytology - 13% normal, 8% low-grade and 7.5% suspicious for cancer. Across all FIGO stages at diagnosis, 5-10% of cytology was low grade, 3-11.5% was positive for carcinoma and 4-41% was normal, which increased with advancing stage. For all cytology and FIGO stages (except stage 1A), OBGYNs had a significantly shorter time to diagnosis compared to family physicians. Factors increasing the odds of low-grade cytology were advanced stage (OR 4.5 (2.4-8.0), p < 0.01) and adenocarcinoma (OR 1.5 (1.1-2.1), p < 0.01). Low grade cytology resulted in the longest delay to diagnosis (p < 0.001).

CONCLUSION

Pap tests are performed frequently in the 0-2 years prior to the diagnosis of cervical cancer which can result in false negative cytology and diagnostic delay in patients with advanced cancers.

摘要

目的

评估巴氏涂片检查对宫颈癌诊断时间的影响。

方法

在这项基于人群的回顾性队列研究中,确定了 2011 年至 2014 年间在安大略省被诊断患有宫颈癌的年龄≥21 岁的女性,并收集了数据库数据。确定癌症诊断前 0-2 年内是否进行了巴氏涂片检查。进行描述性和建模分析以确定巴氏涂片结果对癌症诊断的影响。

结果

共确定了 2002 名患者,其中 75%接受了巴氏涂片检查。1250 名患者有已知的细胞学检查结果-13%正常,8%低级别和 7.5%疑似癌症。在所有诊断时的 FIGO 分期中,5-10%的细胞学为低级别,8-11.5%为癌前病变阳性,4-41%为正常,随着分期的进展而增加。对于所有细胞学和 FIGO 分期(IA1 期除外),妇产科医生的诊断时间明显短于家庭医生。增加低级别细胞学的可能性的因素包括晚期(OR 4.5(2.4-8.0),p<0.01)和腺癌(OR 1.5(1.1-2.1),p<0.01)。低级别细胞学导致诊断延迟时间最长(p<0.001)。

结论

在宫颈癌诊断前 0-2 年内经常进行巴氏涂片检查,这可能导致假阴性细胞学检查并导致晚期癌症患者的诊断延迟。

相似文献

1
Pap tests in the diagnosis of cervical cancer: Help or hinder?巴氏涂片检查在宫颈癌诊断中的作用:是帮助还是阻碍?
Gynecol Oncol. 2018 Jul;150(1):61-66. doi: 10.1016/j.ygyno.2018.05.019.
2
Risk factors of cervical cancer after a negative cytological diagnosis in Polish cervical cancer screening programme.波兰宫颈癌筛查项目中细胞学阴性诊断后的宫颈癌风险因素。
Cancer Med. 2021 May;10(10):3449-3460. doi: 10.1002/cam4.3857. Epub 2021 May 2.
3
Glandular Lesions of the Cervix in Clinical Practice: A Cytology, Histology, and Human Papillomavirus Correlation Study From 2 Institutions.临床实践中宫颈的腺性病变:一项来自两家机构的细胞学、组织学与人乳头瘤病毒相关性研究
Arch Pathol Lab Med. 2015 Nov;139(11):1431-6. doi: 10.5858/arpa.2014-0633-OA. Epub 2015 May 7.
4
Conventional Pap smear and liquid-based cytology as screening tools in low-resource settings in Latin America: experience of the Latin American screening study.传统巴氏涂片和液基细胞学检查作为拉丁美洲资源匮乏地区的筛查工具:拉丁美洲筛查研究的经验
Acta Cytol. 2005 Sep-Oct;49(5):500-6. doi: 10.1159/000326195.
5
History of high-risk HPV and Pap test results in a large cohort of patients with invasive cervical carcinoma: experience from the largest women's hospital in China.中国最大的妇女医院的经验:一大群浸润性宫颈癌患者的高危人乳头瘤病毒感染史和巴氏试验结果
Cancer Cytopathol. 2015 Jul;123(7):421-7. doi: 10.1002/cncy.21545. Epub 2015 May 8.
6
How useful are cervical Pap smears in detecting endometrial carcinomas? A tertiary cancer center experience.宫颈涂片在检测子宫内膜癌中的作用有多大?一家三级癌症中心的经验。
Diagn Cytopathol. 2021 Jan;49(1):127-131. doi: 10.1002/dc.24609. Epub 2020 Sep 10.
7
A study of Pap test history and histologically determined cervical cancer in NSW women, 1997-2003.1997 - 2003年新南威尔士州女性巴氏试验史与组织学确诊宫颈癌的研究
J Med Screen. 2005;12(4):190-6. doi: 10.1258/096914105775220769.
8
Screening frequency and histologic type influence the efficacy of cervical cancer screening: A nationwide cohort study.筛查频率和组织学类型影响宫颈癌筛查效果:一项全国性队列研究。
Taiwan J Obstet Gynecol. 2017 Aug;56(4):442-448. doi: 10.1016/j.tjog.2017.01.010.
9
Is a liquid-based cytology more sensitive than a conventional Pap smear?液基细胞学检查比传统巴氏涂片检查更敏感吗?
Cytopathology. 2013 Aug;24(4):254-63. doi: 10.1111/cyt.12037. Epub 2013 Jan 20.
10
Cervical cancer screening for survivors diagnosed with cancer before age 25.25 岁以前被诊断患有癌症的幸存者的宫颈癌筛查。
J Cancer Surviv. 2017 Jun;11(3):410-419. doi: 10.1007/s11764-017-0598-z. Epub 2017 Jan 27.

引用本文的文献

1
Cervical cancer prevention behaviors in young Black women.年轻黑人女性的宫颈癌预防行为
Womens Health (Lond). 2025 Jan-Dec;21:17455057251326008. doi: 10.1177/17455057251326008. Epub 2025 Mar 27.
2
Predicting cervical cancer screening participation using self-care behaviors among women in Iran.利用伊朗女性的自我护理行为预测宫颈癌筛查参与情况。
J Educ Health Promot. 2024 Jul 29;13:257. doi: 10.4103/jehp.jehp_704_23. eCollection 2024.
3
Evaluation of Exosomal miRNA as Potential Biomarkers in Cervical Cancer.外泌体微小RNA作为宫颈癌潜在生物标志物的评估
Epigenomes. 2023 Aug 1;7(3):16. doi: 10.3390/epigenomes7030016.
4
Barriers and facilitators to cervical cancer screening among under-screened women in Cuenca, Ecuador: the perspectives of women and health professionals.厄瓜多尔昆卡市未充分筛查女性宫颈癌筛查的障碍和促进因素:女性和卫生专业人员的观点。
BMC Public Health. 2022 Nov 22;22(1):2144. doi: 10.1186/s12889-022-14601-y.
5
An Electroanalytical Flexible Biosensor Based on Reduced Graphene Oxide-DNA Hybrids for the Early Detection of Human Papillomavirus-16.一种基于还原氧化石墨烯-DNA杂交体的电化学柔性生物传感器用于人乳头瘤病毒16型的早期检测
Diagnostics (Basel). 2022 Aug 28;12(9):2087. doi: 10.3390/diagnostics12092087.
6
Cervical Cancer in Women with Normal Papanicolaou Tests: A Korean Nationwide Cohort Study.正常巴氏涂片检查女性中的宫颈癌:一项韩国全国队列研究。
Cancer Res Treat. 2021 Jul;53(3):813-818. doi: 10.4143/crt.2020.826. Epub 2020 Dec 10.
7
Diagnostic Role of Papanicolaou Smear, Hemoglobin, Blood Group, and Other Clinical Symptoms in Detecting Endometrial Carcinoma: A Clinicopathological Study of 175 Iranian Women with Endometrial Carcinoma.巴氏涂片、血红蛋白、血型及其他临床症状在子宫内膜癌诊断中的作用:对175例伊朗子宫内膜癌女性患者的临床病理研究
Gynecol Minim Invasive Ther. 2020 Aug 1;9(3):131-138. doi: 10.4103/GMIT.GMIT_93_19. eCollection 2020 Jul-Sep.
8
DNA Biosensor Based on Double-Layer Discharge for the Detection of HPV Type 16.基于双层放电的 HPV 16 型 DNA 生物传感器检测
Sensors (Basel). 2019 Sep 13;19(18):3956. doi: 10.3390/s19183956.
9
Estrogen receptor 1 mutations in 260 cervical cancer samples from Chinese patients.260例中国患者宫颈癌样本中的雌激素受体1突变
Oncol Lett. 2019 Sep;18(3):2771-2776. doi: 10.3892/ol.2019.10612. Epub 2019 Jul 15.
10
Clinical value of combined detection of miR-1202 and miR-195 in early diagnosis of cervical cancer.miR-1202和miR-195联合检测在宫颈癌早期诊断中的临床价值
Oncol Lett. 2019 Mar;17(3):3387-3391. doi: 10.3892/ol.2019.9956. Epub 2019 Jan 22.